Market revenue in 2023 | USD 1,189.8 million |
Market revenue in 2030 | USD 1,705.7 million |
Growth rate | 5.3% (CAGR from 2023 to 2030) |
Largest segment | Anti-infective |
Fastest growing segment | Chemotherapy |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 26.82% in 2023. Horizon Databook has segmented the Latin America home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
The market in Latin America is expected to witness a steady growth during the forecast period owing to rising number of people living with chronic diseases and cardiac disorders. In addition, economic conditions, along with lack of reimbursement for home healthcare services, is expected to present market players with significant growth opportunities.
Moreover, rising number of initiatives by government to promote home infusion, such as the initiation of home infusion program for the treatment of Fabry disease in Argentina in 2013, is likely to contribute to market growth in this region during the forecast period. Increasing number of homecare establishments for patients with chronic diseases & disability is also expected to fuel market growth in Latin America during the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America home infusion therapy market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account